BioSpace News Archive

Q-State Biosciences Announces the Appointment of Biopharma Veteran Paul Medeiros as President and Chief Executive Officer CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Q-State Biosciences (“Q-State”), a precision therapeutics company developing treatments for diseases associated with electrically excitable cells, announced today the appointment of Paul Medeiros as President and Chief Executive Officer of the company. With nearly 25 years of global executive pharmac

FH Ortho, Inc. a long standing, well respected manufacturer of innovative orthopedic implantable devices is pleased to announce the FDA clearance of its e-Ortho planning software that will further expand the Arrow Prime Shoulder Arthroplasty platform. Jean-Marc Idier, President and CEO of FH Ortho, stated, “e-Ortho demonstrates our commitment to advancements in shoulder arthroplasty by providing our customers with increased value through a means of

-- World-class germline and somatic testing, liquid biopsy and tissue genomic profiling, now delivered from a single platform with unrivaled breadth and flexibility --

Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced the appointment of Ann Miller, M.D., to its board of directors. “Ann is an experienced and successful industry executive, who has built multiple high-performing commercial teams and successfu

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from psychiatric disorders, announced that Sara Grubbs has been appointed as the company’s Vice President, Sales effective immediately. “We are thrilled to bring in a proven commercial mind of Sara’s caliber. In my 30 years of managing sales teams and managers, I rank Sara as one of the top sales strategist and t

BioLife Sciences Inc. (OTC Markets: BLFE) is introducing non-contact human temperature screening to its lineup of products designed to provide businesses with cost-effective solutions to successfully navigate through the current health crisis. BioLife Sciences’ non-contact human temperature screening technology offers state-of-the-art, intelligent thermal imaging technology. The AI Screening Technology can measure temperature and

The study met its pre-specified efficacy endpoints and showed that OCS-01 eye drops were more effective than vehicle in reducing central macular thickness and improving visual acuity in patients with DME No significant unanticipated ocular adverse events were observed Phase 3 trial for OCS-01 in DME is in preparation following positive End-of-Phase 2 meeting with FDA Results were presented by renowned retina specialist Prof. Ramin Tadayoni, M.D., Ph.D. LAUSANNE, Switzerland, Oct. 05, 2020

The Evanston Group, a life sciences consulting firm that provides executive consulting, program and project leadership, subject matter expertise, and advisory services to clients in the pharmaceuticals & biologics and medical devices industries, announced today the appointment of Michael Romero as Chief Executive Officer.

LexisNexis® Risk Solutions, a leading provider of data, analytics and technology for the insurance industry, and ExamOne®, a Quest Diagnostics company and leading laboratory and prescription history data provider for life insurance, announced a strategic relationship to offer insurance carriers a next-generation life mortality model to underwrite new policies

With rising numbers of Americans testing positive for COVID-19, including President Trump, the COLCORONA trial adds enrollment sites in the United States and including locations in Mississippi, Arizona, Minnesota, South Carolina, North Carolina and Florida.